Back to Search
Start Over
Particulate matter-induced epigenetic modifications and lung complications.
- Source :
-
European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2024 Nov 13; Vol. 33 (174). Date of Electronic Publication: 2024 Nov 13 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Air pollution is one of the leading causes of early deaths worldwide, with particulate matter (PM) as an emerging factor contributing to this trend. PM is classified based on its physical size, which ranges from PM <subscript>10</subscript> (diameter ≤10 μm) to PM <subscript>2.5</subscript> (≤2.5 μm) and PM <subscript>0.5</subscript> (≤0.5 μm). Smaller-sized PM can move freely through the air and readily infiltrate deep into the lungs, intensifying existing health issues and exacerbating complications. Lung complications are the most common issues arising from PM exposure due to the primary site of deposition in the respiratory system. Conditions such as asthma, COPD, idiopathic pulmonary fibrosis, lung cancer and various lung infections are all susceptible to worsening due to PM exposure. PM can epigenetically modify specific target sites, further complicating its impact on these conditions. Understanding these epigenetic mechanisms holds promise for addressing these complications in cases of PM exposure. This involves studying the effect of PM on different gene expressions and regulation through epigenetic modifications, including DNA methylation, histone modifications and microRNAs. Targeting and manipulating these epigenetic modifications and their mechanisms could be promising strategies for future treatments of lung complications. This review mainly focuses on different epigenetic modifications due to PM <subscript>2.5</subscript> exposure in the various lung complications mentioned above.<br />Competing Interests: Conflict of interest: All the authors have nothing to disclose.<br /> (Copyright ©The authors 2024.)
- Subjects :
- Humans
Animals
Risk Factors
MicroRNAs genetics
MicroRNAs metabolism
Inhalation Exposure adverse effects
Particle Size
Genetic Predisposition to Disease
Phenotype
Risk Assessment
Particulate Matter adverse effects
Epigenesis, Genetic drug effects
Lung Diseases genetics
Lung Diseases chemically induced
Lung drug effects
Lung metabolism
Lung physiopathology
Lung pathology
DNA Methylation drug effects
Air Pollutants adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1600-0617
- Volume :
- 33
- Issue :
- 174
- Database :
- MEDLINE
- Journal :
- European respiratory review : an official journal of the European Respiratory Society
- Publication Type :
- Academic Journal
- Accession number :
- 39537244
- Full Text :
- https://doi.org/10.1183/16000617.0129-2024